Beyond biomarkers: An opportunity to address the 'pharmacodynamic gap in pediatric drug development

Biomarkers in Medicine

Volumn 4, Issue 6, 2010, Pages 783-786

  Kearns, Gregory L ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

biomarkers; pediatrics; pharmacodynamic

Indexed keywords

BIOLOGICAL MARKER; NEW DRUG;

ACCURACY; CHILD HEALTH CARE; DRUG EFFECT; DRUG LABELING; DRUG RESEARCH; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; INDIVIDUALIZATION; MEDICAL DECISION MAKING; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTION; RESEARCH ETHICS; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

BIOMARKERS, PHARMACOLOGICAL; DECISION TREES; DRUG DISCOVERY; ENDPOINT DETERMINATION; HUMANS; PEDIATRICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78650745162     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.10.106     Document Type: Review

References (12)

1. Wagner JA: Biomarkers: principles, policies and practice. Clin. Pharmacol. Ther. 86, 3-7 (2009).
2. Wagner JA, Williams SA, Webster CJ: Biomarkers and surrogate end points for ft-for-purpose development and regulatory evaluation of new drugs. Clin. Pharmacol. Ther. 81, 104-107 (2007).
3. Wilson C, Schulz S, Waldman SA: Biomarker development, commercialization, and regulation: individualization of medicine lost in translation. Clin. Pharmacol. Ther. 81, 153-155 (2007).
4. Lathia CD, Amakye D, Dai W et al.: The value, qualifcation and regulatory use of surrogate end points in drug development. Clin. Pharmacol. Ther. 86, 32-43 (2009).
5. Gobburu JVS: Biomarkers in clinical drug development. Clin. Pharmacol. Ther. 86, 26-27 (2009).
6. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE: Developmental pharmacology - drug disposition, action and therapy in infants and children. N. Engl. J. Med. 349, 1157-1167 (2003).
7. Mulla H: Understanding developmental pharmacodynamics: importance for drug development and clinical practice. Paediatr. Drugs 12, 223-233 (2010).
8. Holford N: Dosing in children. Clin. Pharmacol. Ther. 87, 367-370 (2010).
9. Ibrahim AE, Feldman J, Karim A, Kharasch ED: Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil. Anesthesiology 98, 853-861 (2003).
10. Neville KA, Anderson R, Griggs M, Peter S, Connelly M: Pupillometry: a tool to measure pharmacodynamic effect of analgesic drugs in pediatrics. Clin. Pharmacol. Ther. 8 7, S65-S66 (2010).
11. Jones BL, Abdel-Rahman SM, Simon SD, Kearns GL, Neville KA: Assessment of histamine pharmacodynamics by microvascular response of histamine using histamine iontophoresis laser doppler fowimetry. J. Clin. Pharmacol. 49, 600-605 (2009).
12. Jones BL, Pearce RE, Abdel-Rahman SM, Friesen CA, James LP, Kearns GL: Characterization of delayed gastric emptying in children by the 13C-acetate breath test. J. Breath Res. 3, 1-6 (2009).